Immunomodulatory Effect of G2013 (α-L-Guluronic Acid) on the TLR2 and TLR4 in Human Mononuclear Cells.

Keywords

TLR2, TLR4, Peripheral blood mononuclear cell, Receptor, Lipopolysaccharide

References

No references recorded for this paper.

Cited by

• The Inhibitory Role of M2000 (β-D-Mannuronic Acid) on Expression of Toll-like Receptor 2 and 4 in HT29 Cell LineБиар Лубсанович Раднаев, Анна Семеновна Михеева — 2019
• The Immunomodulatory Role of G2013 (α-L-Guluronic Acid) on the Expression of TLR2 and TLR4 in HT29 cell line.Hamid Farhang, Laleh Sharifi, Mohammad Mehdi Soltan Dallal — 2019
• Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in SynucleinopathiesIan F. Caplan, Kathleen A. Maguire‐Zeiss — 2018
• Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasisXu Zhang, Ting Li, Xi Chen — 2018
• Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory propertiesSeyed Shahabeddin Mortazavi‐Jahromi, Sepideh Nazeri, Fahimeh Jafarnezhad‐Ansariha — 2018
• A randomized clinical trial for the assessment of the efficacy and safety of guluronic acid (G2013) in patients with rheumatoid arthritisShahin Khadem Azarian, Maassoumeh Akhlaghi, Mahdi Mahmoudi — 2019
• A Review of Preclinical Experiments Toward Targeting M2 Macrophages in Prostate Cancer.Farhad Seif, Laleh Sharifi, Majid Khoshmirsafa — 2019
• بررسی اثر باکتریهای پروبیوتیک لاکتوباسیلوس اسیدوفیلوس PTCC1643 و لاکتوباسیلوس کازیی PTCC 1608 بر روی بیان ژنهای TLR2 و TLR4 در سلولهای HT29 عفونی شده با سالمونلا انتریتیدیسمحمد مهدی سلطاندلال, منا مشیری, عباس میرشفیعی — 2019
• Co‐expression of TLR‐9 and MMP‐13 is associated with the degree of tumour differentiation in prostate cancerElham Kalantari, Maryam Abolhasani, Raheleh Roudi — 2019
• Effects of guluronic acid (G2013) on gene expression of TLR2, TLR4, MyD88, TNF-α and CD52 in multiple sclerosis under in vitro conditionsSeyedeh Masoomeh Noorbakhsh, Alireza Razavi, Nahid Beladi Moghadam — 2019
• Pivotal cytokines and their transcription factors are the targets of guluronic acid (G2013) for inhibiting the immunopathogenesis process of multiple sclerosisNikoo Hossein‐Khannazer, Samira Shabani, Mohadeseh Farokhfar — 2020
• Advances in Research on the Bioactivity of Alginate OligosaccharidesMaochen Xing, Qi Cao, Yu Wang — 2020
• Evaluation of the oral administration of α‐l‐guluronic acid on COX‐1 and COX‐2 gene expression profile in ankylosing spondylitis patientsArezoo Sadoughi, Reza Mansouri, Sepideh Nazeri — 2020
• Anti-tumor effect of M2000 (β-d-mannuronic acid) on the expression of inflammatory molecules in the prostate cancer cellMonireh Mohsenzadegan, Fatemeh Moghbeli, Abbas Mirshafiey — 2021
• The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditionsSafa Tahmasebi, Hassan Neishaboori, Davood Jafari — 2021
• Evaluation of G2013 (α‐L‐guluronic acid) efficacy on PC‐3 cells through inhibiting the expression of inflammatory factorsZahra Bagherian, Abbas Mirshafiey, Monireh Mohsenzadegan — 2021
• Immuno-modulatory biomaterials as anti-inflammatory therapeutics.Roisin I. Lynch, Ed C. Lavelle — 2022
• Polyguluronic acid alleviates doxorubicin-induced cardiotoxicity by suppressing Peli1-NLRP3 inflammasome-mediated pyroptosis.Erlin Zhang, Chuangeng Shang, Mingtao Ma — 2023
• An Overview on the Function of Probiotics and Their Positive Effects on Enhancing Intestinal Immune ResponsesSeyed Edalat Pishkar, Elaheh Mesdaghinia, Zeinab Yazdanpanah — 2023
• The IL‐23/IL‐17/NF‐κB Signaling Pathway in Rheumatoid Arthritis: Molecular Mechanisms and Therapeutic AgentsJiayi Deng, Yasi Deng, Yuxin Chen — 2025

Related papers

• Besides TLR2 and TLR4, NLRP3 is also involved in regulating Escherichia coli infection-induced inflammatory responses in miceYuan Shen, Zhiguo Gong, Shuangyi Zhang — 2023
• Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation.Emmanuelle Faure, Lisa Thomas, Helen Xu — 2001
• Toll-Like Receptor 4, But Not Toll-Like Receptor 2, Is a Signaling Receptor for Escherichia and Salmonella Lipopolysaccharides1Richard I. Tapping, Sachiko Akashi, Kensuke Miyake — 2000
• Gene Expressions of Toll-Like Receptor 2, But Not Toll-Like Receptor 4, Is Induced by LPS and Inflammatory Cytokines in Mouse Macrophages1Tetsuya Matsuguchi, Tipayaratn Musikacharoen, Tomohiko Ogawa — 2000
• Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine MacrophagesMatthew Hirschfeld, Janis J. Weis, Vladimir Y. Toshchakov — 2001
• Besides TLR2 and TLR4, NLRP3 is also involved in regulating Escherichia coli infection-induced inflammatory responses in mice.Yuan Shen, Zhiguo Gong, Shuangyi Zhang — 2023
• TLR4-Independent Effects of LPS Identified Using Longitudinal Serum ProteomicsErin Harberts, Tao Liang, Sung Hwan Yoon — 2020
• TOLL-LIKE RECEPTORS (TLR) 2 AND 4 EXPRESSION OF KERATINOCYTES FROM PATIENTS WITH LOCALIZED AND DISSEMINATED DERMATOPHYTOSISCristiane Beatriz de Oliveira, Cí­dia Vasconcellos, Neusa Yurico Sakai-Valente — 2015